ROGSX
Price
$55.17
Change
+$0.55 (+1.01%)
Updated
Aug 28 closing price
Net Assets
724.18M
SCMIX
Price
$176.79
Change
+$2.56 (+1.47%)
Updated
Aug 28 closing price
Net Assets
15.75B
Interact to see
Advertisement

ROGSX vs SCMIX

Header iconROGSX vs SCMIX Comparison
Open Charts ROGSX vs SCMIXBanner chart's image
Red Oak Technology Select
Price$55.17
Change+$0.55 (+1.01%)
VolumeN/A
Net Assets724.18M
Columbia Seligman Tech & Info Inst2
Price$176.79
Change+$2.56 (+1.47%)
VolumeN/A
Net Assets15.75B
ROGSX vs SCMIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ROGSX vs. SCMIX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROGSX is a Buy and SCMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SCMIX has more cash in the bank: 15.7B vs. ROGSX (724M). ROGSX (0.00) and SCMIX (0.00) have matching dividends . ROGSX was incepted earlier than SCMIX: ROGSX (27 years) vs SCMIX (24 years). ROGSX (0.92) and SCMIX (0.89) have similar cost to investors . SCMIX is a more actively managed with annual turnover of: 33.00 vs. ROGSX (0.00). SCMIX has a lower initial minimum investment than ROGSX: SCMIX (0) vs ROGSX (2000). ROGSX annual gain was more profitable for investors over the last year : 17.11 vs. SCMIX (15.96). SCMIX return over 5 years is better than : 66.01 vs. ROGSX (49.83).
ROGSXSCMIXROGSX / SCMIX
Total Expense Ratio0.920.89103%
Annual Report Gross Expense Ratio0.920.89103%
Fund Existence27 years24 years-
Gain YTD15.81816.40996%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets724M15.7B5%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.1115.96107%
Returns for 3 years67.3154.75123%
Returns for 5 years49.8366.0175%
Returns for 10 years261.13190.43137%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENTO2.150.24
+12.57%
Entero Therapeutics Inc
ADPT13.310.34
+2.62%
Adaptive Biotechnologies Corp
DRS42.470.44
+1.05%
Leonardo DRS
BZFD2.010.02
+1.01%
BuzzFeed Inc.
MAGN12.32-0.14
-1.12%
Magnera Corporation